GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION CANCER

Clinical trials for GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION CANCER explained in plain language.

Never miss a new study

Get alerted when new GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION CANCER trials appear

Sign up with your email to follow new studies for GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Immune-Boosting drug enters human trials for tough cancers

Disease control Recruiting now

This early-stage study aims to find a safe and effective dose of a new drug called AZD6750, which is designed to boost the immune system to fight cancer. It will test the drug alone and combined with other cancer treatments in about 60 adults with advanced or spreading solid tumo…

Matched conditions: GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION CANCER

Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION CANCER

Get alerted when new GASTRIC CANCER/GASTROESOPHAGEAL JUNCTION CANCER trials appear

New Immune-Boosting drug enters human trials for tough cancers